We are live on ! Find out more
LPC

Lone Pine Capital Portfolio holdings

AUM $12.5B
1-Year Est. Return 54.4%
This Fund
S&P 500
This Quarter Est. Return
+24.11%
1 Year Est. Return
+54.4%
3 Year Est. Return
+215.45%
5 Year Est. Return
+217.84%
10 Year Est. Return
+1,364.6%
AUM
$14.1B
AUM Growth
+$2.47B
Cap. Flow
-$64.9M
Cap. Flow %
-0.46%
Top 10 Hldgs %
60.8%
Holding
29
New
5
Increased
5
Reduced
11
Closed
5

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$647M
2
EQT icon
EQT Corp
EQT
+$406M
3
WIX icon
WIX.com
WIX
+$348M
4
BN icon
Brookfield
BN
+$312M
5
BKNG icon
Booking.com
BKNG
+$307M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$456M
2
INTU icon
Intuit
INTU
+$428M
3
TOL icon
Toll Brothers
TOL
+$401M
4
CDNS icon
Cadence Design Systems
CDNS
+$310M
5
ARES icon
Ares Management
ARES
+$235M

Sector Composition

Rank Sector Weight
1 Technology 25.72%
2 Consumer Discretionary 21.98%
3 Financials 17.08%
4 Communication Services 11.89%
5 Utilities 11.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNS icon
26
Cadence Design Systems
CDNS
$90B
-1,218,389
Closed -$310M
LLY icon
27
Eli Lilly
LLY
$1.07T
-551,827
Closed -$456M
TOL icon
28
Toll Brothers
TOL
$14B
-3,800,580
Closed -$401M
WING icon
29
Wingstop
WING
$3.68B
-449,056
Closed -$101M

Similar funds

Lone Pine Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Lone Pine Capital held 29 positions worth $14.1B, up 21% from $11.6B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Lone Pine Capital's Q2 2025 filing shows 5 new, 5 increased, 11 reduced and 5 closed positions. Its largest new stake was UnitedHealth: 1,693,347 shares worth $528M. The largest sale was Eli Lilly, an estimated $456M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Lone Pine Capital's largest Q2 2025 buy was UnitedHealth: 1,693,347 shares worth $528M.
  • Lone Pine Capital added most to Vistra in Q2 2025, an estimated $276M increase.
  • Lone Pine Capital's biggest Q2 2025 reduction was Intuit, cutting an estimated $428M.
  • Lone Pine Capital fully exited Eli Lilly in Q2 2025, selling an estimated $456M.
  • Lone Pine Capital's ten largest holdings make up 61% of its $14.1B portfolio in Q2 2025.
  • Lone Pine Capital opened 5 new positions and closed 5 in Q2 2025.
  • Lone Pine Capital's portfolio value rose 21% quarter-over-quarter to $14.1B.

Based on Lone Pine Capital's 13F filing for Q2 2025, filed 14 Aug 2025.